Membranous nephropathy: When and how to treat

被引：9
作者：
Lai, K. N. [1 ]
机构：
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
来源：
KIDNEY INTERNATIONAL | 2007年 / 71卷 / 09期
关键词：
D O I：
10.1038/sj.ki.5002201
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
The treatment of idiopathic membranous nephropathy is heavily debated because of wide variation in outcome. A rational treatment strategy is needed to appropriately administer conservative treatment to the low-risk group but immunosuppressive therapy to those with medium or high risk of renal deterioration. Currently, combinations of steroids with alkylating agents are best studied. Newer forms of immunosuppressive treatment are currently under study.
引用
收藏
页码：841 / 843
页数：3
相关论文
共 10 条
[1]   THE MEDICAL-RESEARCH-COUNCIL TRIAL OF SHORT-TERM HIGH-DOSE ALTERNATE DAY PREDNISOLONE IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH NEPHROTIC SYNDROME IN ADULTS [J].
CAMERON, JS ;
HEALY, MJR ;
ADU, D .
QUARTERLY JOURNAL OF MEDICINE, 1990, 74 (274) :133-156
[2]   Management of membranous nephropathy: When and what for treatment [J].
Cattran, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (05) :1188-1194
[3]   A CONTROLLED TRIAL OF CYCLOSPORINE IN PATIENTS WITH PROGRESSIVE MEMBRANOUS NEPHROPATHY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S ;
BERNSTEIN, K ;
CHURCHILL, DN ;
CLARK, WF ;
MORRIN, PA ;
LAVOIE, S .
KIDNEY INTERNATIONAL, 1995, 47 (04) :1130-1135
[4]   Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial [J].
Cattran, DC ;
Appel, GB ;
Hebert, LA ;
Hunsicker, LG ;
Pohl, MA ;
Hoy, WE ;
Maxwell, DR ;
Kunis, CL .
KIDNEY INTERNATIONAL, 2001, 59 (04) :1484-1490
[5]   A RANDOMIZED CONTROLLED TRIAL OF PREDNISONE IN PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY [J].
CATTRAN, DC ;
DELMORE, T ;
ROSCOE, J ;
COLE, E ;
CARDELLA, C ;
CHARRON, R ;
RITCHIE, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (04) :210-215
[6]   Idiopathic membranous nephropathy: Outline and rationale of a treatment strategy [J].
du Buf-Vereijken, PWG ;
Branten, AJW ;
Wetzels, JFM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 46 (06) :1012-1029
[7]   Use of mycophenolate mofetil in resistant membranous nephropathy [J].
Miller, G ;
Zimmerman, R ;
Radhakrishnan, J ;
Appel, G .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (02) :250-256
[8]   CONTROLLED TRIAL OF METHYLPREDNISOLONE AND CHLORAMBUCIL IN IDIOPATHIC MEMBRANOUS NEPHROPATHY [J].
PONTICELLI, C ;
ZUCCHELLI, P ;
IMBASCIATI, E ;
CAGNOLI, L ;
POZZI, C ;
PASSERINI, P ;
GRASSI, C ;
LIMIDO, D ;
PASQUALI, S ;
VOLPINI, T ;
SASDELLI, M ;
LOCATELLI, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (15) :946-950
[9]   Tacrolimus monotherapy in membranous nephropathy:: A randomized controlled trial [J].
Praga, M. ;
Barrio, V. ;
Fernandez Juarez, G. ;
Luno, J. .
KIDNEY INTERNATIONAL, 2007, 71 (09) :924-930
[10]  
SCHIEPPATI A, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004293
1